These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19225818)

  • 21. Photodynamic therapy combined with intravitreal bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Lazić R; Gabrić N; Dekaris I; Gavrić M; Bosnar D
    Coll Antropol; 2007 Jan; 31 Suppl 1():71-5. PubMed ID: 17469756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for occult and classic CNV in AMD].
    Maier M; Haas K; Feucht N; Fiore B; Winkler von Mohrenfels C; Clos A; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):653-9. PubMed ID: 18642209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Costagliola C; Romano MR; Rinaldi M; dell'Omo R; Chiosi F; Menzione M; Semeraro F
    Br J Ophthalmol; 2010 Feb; 94(2):180-4. PubMed ID: 19965822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination photodynamic therapy and intravitreal ranibizumab in neovascular AMD in a north Indian population: a pilot study.
    Kumar A; Gopalakrishnan K; Sinha S
    Retina; 2008 Oct; 28(8):1132-7. PubMed ID: 18779720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization.
    Yoon JU; Byun YJ; Koh HJ
    Retina; 2010 Mar; 30(3):418-24. PubMed ID: 20094012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
    Augustin AJ; Puls S; Offermann I
    Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration.
    Nowak MS; Jurowski P; Grzybowski A; Goś R; Pastuszka M; Kapica A; Śmigielski J
    Med Sci Monit; 2012 Jun; 18(6):CR374-80. PubMed ID: 22648253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.
    Bakri SJ; Couch SM; McCannel CA; Edwards AO
    Retina; 2009 May; 29(5):573-8. PubMed ID: 19430278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study.
    Saviano S; Leon PE; Mangogna A; Tognetto D
    Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination photodynamic therapy and intravitreal ranibizumab in neovascular age-related macular degeneration in a North Indian population: a pilot study.
    Kumar A; Gopalakrishnan K; Sinha S
    Retina; 2008 Oct; 28(9):1296-301. PubMed ID: 18667951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
    Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
    Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: the VIA study.
    Potter MJ; Claudio CC; Szabo SM
    Br J Ophthalmol; 2010 Feb; 94(2):174-9. PubMed ID: 19520690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.
    Shima C; Gomi F; Sawa M; Sakaguchi H; Tsujikawa M; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):899-906. PubMed ID: 19308441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients.
    Hara R; Kawaji T; Inomata Y; Tahara J; Sagara N; Fukushima M; Tanihara H
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):931-6. PubMed ID: 20221623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Ahadi H
    Eur J Ophthalmol; 2008; 18(2):297-300. PubMed ID: 18320527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.